title: [A controlled experience with a thermostabile measles vaccine in Cameroon (author's transl)].
abstract: Rimevax, a thermostabile measles vaccine, has been stored, before reconstitution, during seven days at temperature from 23 degrees C to 25 degrees C. This vaccine has given seroconversion in 87 per 100 of the babies vaccinated and aged from 9 to 24 months. This percentage assesses the value of Rimevax for field campaigns.
mesh_terms: D000367:Age Factors; D002163:Cameroon; D006801:Humans; D007223:Infant; D008457:Measles / Q000517:prevention & control*; D008458:Measles Vaccine / Q000008:administration & dosage*; D013696:Temperature
chemical_list: D008458:Measles Vaccine
vernacular_title: Essai contrôlé d'un vaccin antirougeoleux thermostable au Cameroun.